Submitting a Letter of Intent (LOI) for a PCORI grant? This step is more than a formality; it’s the first chance to demonstrate that your study is patient-centered, innovative, and impactful. One of the biggest challenges research teams face at this stage is showing meaningful patient engagement. Reviewers are actively looking at the LOI for evidence that patients’ perspectives shape the study.
In today’s research environment, patient-centeredness is no longer a philosophical aspiration; it is a requirement – and it’s one that can be measured! Nowhere is this more evident than in proposals to the Patient-Centered Outcomes Research Institute (PCORI), where reviewers expect early proof that a study is shaped with patients rather than simply about them. The challenge, however, is that demonstrating meaningful patient engagement at the Letter of Intent (LOI) stage can be difficult.
This is where patient-centric technology plays a critical role: including technology purpose-built to engage participants can demonstrate robust stakeholder engagement, even at the LOI stage.
For researchers that have never applied for funding with PCORI, these grants provide funding via the Patient-Centered Outcomes Research Institute. These funding mechanisms support comparative clinical effectiveness research (CER) that helps patients, caregivers, and clinicians make better-informed healthcare decisions.
Unlike many NIH research grants that focus primarily on scientific discovery or mechanistic understanding, PCORI-funded studies must start with the questions and outcomes that matter most to patients. PCORI emphasizes real-world relevance, stakeholder involvement, and outcomes that directly influence daily health decisions. Every funded study must show how patients, caregivers, clinicians, and community stakeholders are actively engaged throughout the research lifecycle, from shaping the research question to interpreting and disseminating results.
What makes PCORI grants fundamentally different is that they are built on a patient-first framework, not a researcher-first one. PCORI reviewers expect to see meaningful engagement, transparent communication, and methods that reduce participant burden while increasing inclusivity and real-world applicability. Studies must compare interventions or approaches already used in practice, rather than testing speculative or early-stage concepts. As a result, a competitive PCORI LOI or proposal looks less like a traditional research plan and more like a collaborative partnership between investigators and the populations they serve. It should demonstrate that you listen to the patient voice, prioritize shared decision-making, and ensure that findings will translate into actual improvements in health outcomes and healthcare delivery.
PCORI’s entire funding model is built on a simple but transformative expectation: research must begin with the lived experiences, priorities, and decision-making needs of patients and caregivers. The focus on real-world relevance means investigators must show, even at the LOI stage, that they understand their patient population, have listened to their concerns, and are prepared to design a study that reflects those perspectives from day one.
Because of this emphasis, PCORI reviewers are looking for more than a compelling research question. They are looking for signs that the proposed study has been shaped with patients, not merely for them. They want to know that the outcomes being measured are meaningful in daily life, that the methods minimize participant burden, and that the study reflects clinical scenarios and choices that patients and clinicians confront in the real world.
At the LOI stage, you need to communicate:
Patient-centric technology enhances a PCORI LOI by demonstrating that the proposed study will meet participants where they are. Instead of requiring in-person visits or burdensome manual processes across multiple systems, digital platforms enable continuous, low-effort data collection from multiple sources: patient-reported outcomes, wearable devices, biospecimen tracking, surveys, and real-world data streams. This reduces the workload on participants while expanding the richness of the dataset researchers can access. Equally important, these technologies support sustained engagement through reminders, multilingual interfaces, flexible participation options, and ongoing communication that keeps participants informed and connected to the study’s purpose.
Vibrent’s platform has been validated across large, diverse national research programs, and including it in your LOI is a credible, evidence-based way to show that the study can adopt best practices from programs like the All of Us Research Program.
We can strengthen your LOI and final submission by demonstrating how we can work together to:
Streamline participation by allowing patients to contribute information on their own schedule through mobile and web-based tools. This makes it easier to capture longitudinal patient-reported outcomes, biospecimens, eConsent, and real-world data from multiple sources without adding extra strain on participants.
Leverage Vibrent to integrate data from surveys, devices, and other digital health sources, ensuring that your study captures a rich, holistic view of patient experiences. This makes it possible to gather more actionable insights across larger, more diverse populations.
Demonstrate a clear plan for keeping participants informed, motivated, and actively involved throughout the study. Vibrent’s tools provide reminders, multilingual support, and flexible engagement options, showing that participant involvement is both measurable and sustained.
By referencing these capabilities in your LOI, you show PCORI reviewers that patient-centered design is woven into every aspect of your study, from participation logistics to data collection to ongoing engagement-not simply an afterthought.
Describing the patient-centric technology is one of the parts of your LOI that can demonstrate how you will measure success, and that can demonstrate validated methods.
Today there are numerous publications that validate the use of Vibrent’s technologies in diverse populations, and those precedents can strengthen your LOI by providing reviewers with concrete evidence that your study is feasible, participant-focused, and informed by tools already validated in large, diverse research programs.
When describing Vibrent in your LOI:
Incorporating patient-centric technology into your PCORI LOI sends a powerful signal to reviewers: your study is designed around participants, grounded in real-world evidence, and equipped to collect meaningful data with minimal burden. By demonstrating the ability to engage patients effectively, capture longitudinal and multi-source outcomes, and leverage validated, scalable platforms like Vibrent, your LOI moves from concept to credibility.
If you’re preparing a PCORI submission, we can provide you with content and use cases that can strengthen your LOI and project materials.
When you are ready to explore how Vibrent can strengthen your patient engagement strategy, reduce participant burden, and showcase feasibility, request a meeting with our team to discuss your grant and explore tailored solutions.
Paper Newly Published in JMIR Demonstrates the Efficacy of Digital Platforms to Increase Engagement with Diverse Populations in Health Research
FAIRFAX, Va.--25 Jan., 2025--A pioneering study titled "Building a Digital Health Research Platform to Enable Recruitment, Enrollment, Data Collection, and…
Transforming a National Lung Cancer Registry for Scale, Inclusion, and Real-World Research Impact
How Vibrent modernized the GO2 registry to fulfill its mission of patient advocacy, patient support/education and research. ObjectivesMigrate existing data…
Transforming Population Registries at Scale: Lessons from the All of Us Program (US NIH)
How Vibrent’s platform powered the most diverse, digital-first cohort in US history—and what it means for UK’s registries Problem: UK…
Vibrent Health partners with Fred Hutchinson Cancer Center to Validate a Landmark BARDA-funded Large-Scale Hybrid/Remote Approach for NextGen Clinical Research
Bringing Infectious Disease Research to People Where They Live and Play FAIRFAX, Va.--12 Feb., 2025--Vibrent Health, a leading software-as-a-service SaaS…
eConsent Done Right: A Powerful Tool to Build Trust and Diversity in Research
Researchers use a variety of tools and techniques to reach out and recruit diverse participants to their studies. But the…
St. Jude Chooses Vibrent to Power the Next-Generation of the Childhood Cancer Long-Term Follow-Up Study
OverviewSt. Jude Children’s Research Hospital has long been a leader in pediatric cancer research and survivorship care. One of its…
Are Your Digital Tools an Unintended Barrier to Diversity in Research? How to Bridge the Technology Gap for Research Participants
Since the start of the pandemic, researchers have faced additional challenges in participant recruitment and engagement. Safety and exposure concerns…
Modernizing Remote and Hybrid Clinical Trials Sponsored by the US Biomedical Advanced Research and Development Authority (BARDA) for Mission-Critical Infectious Disease Studies
Problem StatementTraditional site-based clinical trials faced challenges such as limited reach, high costs, prolonged timelines, significant patient burden due to…
To Recruit Diverse Research Participants, Get Out of the Clinic and into Your Community
Most research studies are performed in clinic-based academic medical center facilities. Centralizing resources – technology, laboratory facilities, and skilled clinical…
Reducing the burden and cost of mental healthcare in the UK
The Challenge: A System Under StrainAccording to BMA, good mental health is essential to a functioning society. Mental health problems…